NCBiotech News

Kriya Therapeutics is poised to revolutionize gene therapies for highly serious diseases like diabetes and severe obesity after landing a whopping $100 million in capital.

Durham-based Bioventus, a global med tech company which went public earlier this year, is releasing a new product to its lineup that uses human tissue to improve bone fusions.

A new training program at Durham Tech will prepare students for good-paying entry-level jobs in North Carolina’s growing agricultural biotechnology industry beginning this fall

Durham-based Xilis has raised $70 million in Series A financing to advance its precision oncology platform.

Cary med tech startup Lucerno Dynamics has landed a critical partnership with Siemens Healthineers, one of the world's largest healthcare suppliers.

Laura Gunter, M.B.A, has been selected as the new president of NCBIO, the N.C. Biosciences Organization, succeeding longtime president Sam Taylor who died in February.

A new biopsy sheath developed by Raleigh med tech startup UVision360 is ready to hit the market after landing federal approval this week.

When COVID-19 upended his college aspirations, Carl May deferred his freshman year to battle the bug in his family business, Andersen Sterilizers, processing millions of swabs at the company's Morrisville contract sterilization facility and learning much in the process.

North Carolina military service members are taking the next step in their careers thanks to a program linking their interpersonal and leadership skills with targeted technical training. 

Jellatech is a Raleigh startup that is developing a process producing the same collagen that comes from animals --without using any animals.

British dermatology CDMO MedPharm is actively hiring as it spools up manufacturing operations at its new 15,000-square-foot Morrisville site.

A Raleigh biotechnology startup is putting an initial $26 million investment into the establishment of a teamwork approach to enhance efficiencies for cell- and gene-based cancer therapy developers.

Heat Biologics says it is doubling the size of its R&D facilities in Morrisville to some 15,000 square feet, to better support its drug development programs.

NCBiotech board member Michelle Berrey, M.D., has been appointed the president of research & development and chief medical officer at New-York-based biopharmaceutical innovator Intercept Pharmaceuticals.

Raleigh-based Veranex and global investment firm Summit Partners said they are joining forces to create a soup-to-nuts service provider for the medical technology industry.